Serafin, Retchel Mae E.

HRN: 02-25-28  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/27/2022
CEFUROXIME 1.5GM (VIAL)
12/27/2022
01/03/2023
IVTT
1.3g
Q8
UTI;URTI
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Urinary TractURTI    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: